You may have seen headlines recently claiming peptides like MOTS C or BPC 157 are back let's talk about what this means. In 2023, the FDA placed 19 commonly used peptides into Category FDA Peptide Reclassification 2026: What Researchers Want FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026) The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them HHS Peptides Move: Compounding Pharmacy Concerns Scott Brunner, CAE posted on the topic LinkedIn